• Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
  • Registry
  • ERBP
  • Working Groups
    • CKD-MBD
    • DESCARTES
    • DIABESITY
    • ERN
    • EUDIAL
    • EURECA-m
    • IWG
    • WGIKD
  • Committees
    • SAB
    • YNP
    • ECC
    • GNC
    • NPPC
    • Ethics Committee
    • Registry
    • ERBP
ERA-EDTA
  • ABOUT ERA-EDTA
      • WHO WE ARE
      • History
      • ERA-EDTA Facts and Dates
      • Pioneers of the European Nephrology
        • Interviews with the Masters of Nephrology
      • Obituaries
      • Mission
      • ORGANIZATION & GOVERNANCE
      • Council
        • Council Members
        • Past Council Members
        • Committees, Roles and Terms
        • Candidatures Boards and Calls
      • ORGANIZATION & GOVERNANCE
      • Group & Staff
        • ERA-EDTA
          • ERA-EDTA Operative Headquarters
        • ERA-Eurocongress Ltd
      • Constitution
      • Code of Conduct
      • Disclosure of Interest (DoI)
      • Annual Reports
      • Accounts
      • ERA-EDTA Membership
      • Benefits
      • Fees
      • Renewal
      • Members: Senior – Junior
      • Honorary Members
      • AWARDS
      • Awards 2020
      • Awards 2019
      • Awards 2018
      • ERA-EDTA Distinguished Fellow (FERA)
  • CONGRESS & MEETINGS
    • Berlin 2021
    • Paris 2022
    • Past Congresses
    • Scientific and Educational Interaction Day (SEID)
    • CTDay
    • CEPD
    • ERA-EDTA CME Courses
  • VIRTUAL MEETING
  • SCIENCE
    • Long Term Fellowships
    • Research Programme
    • Registry Fellowships
    • Registry
    • ERACODA
  • EDUCATION
    • NEP-Nephrology Education Portal
    • Virtual Meeting
    • e-seminars
    • GlomCon Webinars
    • Short Term Clinical Fellowships
    • ERA-EDTA CME Courses
    • Patient Information
      • Initiatives for patients
      • Patient Associations
    • ERA-EDTA Endorsement/Non-Financial Support
    • European Specialty Examination in Nephrology (ESENeph)
    • COVID-19 News and Information
  • NETWORKING
  • GUIDELINES
  • JOURNALS & PRESS
      • NDT
      • CKJ
      • Cardio-renal research
      • EDTA Proceedings
      • Newsletter & Press Releases
        • Nephrology News Flash
        • NEP Newsletter
        • Press Releases
      • News
      • EDTA Proceedings
      • Press and Social Media Policies
  • PUBLIC AFFAIRS
    • Collaboration with Societies
    • National Societies
      • National Societies of Nephrology List
    • ASN ERA-EDTA ISN Collaboration
    • EKHA
    • Biomedical Alliance in Europe
    • ERA-EDTA Endorsement/Non-Financial Support
    • Link Exchange
  • Search
  • Menu
  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
  • MEMBERSHIP
  • My Era-Edta
  • Contact us
  • ABOUT ERA-EDTA
    • Who we are
      • History
      • ERA-EDTA Facts and Dates
      • Mission
    • Organization & Governance
      • Council
        • Council Members
        • Past Council Members
        • Committees, Roles and Terms
    • Group & Staff
      • ERA-EDTA
      • ERA-EDTA Operative Headquarters
      • ERA-Eurocongress Ltd
      • Constitution
      • Code of Conduct
      • Annual Reports
      • Accounts
    • ERA-EDTA Membership
      • Benefits
      • Membership Fees
      • Renewal
      • Members: Senior – Junior
    • AWARDS
      • Awards 2020
      • Awards 2019
      • Awards 2018
      • ERA-EDTA Distinguished Fellow (FERA)
  • CONGRESS & MEETINGS
    • Berlin 2021
    • Paris 2022
    • Scientific and Educational Interaction Day (SEID)
    • CTDay
    • CEPD
    • ERA-EDTA CME Courses
  • VIRTUAL MEETING
  • SCIENCE
    • Long Term Fellowships
    • Research Programme
    • Registry Fellowships
    • Registry
    • ERACODA
  • EDUCATION
    • NEP-Nephrology Education Portal
    • Virtual Meeting
    • e-seminars
    • GlomCon Webinars
    • Short Term Clinical Fellowships
    • ERA-EDTA CME Courses
    • Initiatives for patients
    • Patient Associations
    • ERA-EDTA Endorsement/Non-Financial Support
    • European Specialty Examination in Nephrology (ESENeph)
    • COVID-19 News and Information
  • NETWORKING
  • GUIDELINES
  • JOURNALS & PRESS
    • NDT
    • CKJ
    • Cardio Renal Research
    • Newsletter & Press Releases
      • Nephrology News Flash
      • NEP-Nephrology Education Portal Newsletters
      • Press Releases
    • News
    • EDTA PROCEEDINGS
    • Press and Social Media Policies
  • PUBLIC AFFAIRS
    • Collaboration with Societies
    • National Societies
    • ASN ERA-EDTA ISN Collaboration
    • EKHA
    • ERA-EDTA Endorsement/Non-Financial Support
    • Link Exchange
  • Registry
  • ERBP
  • Working Groups
    • CKD-MBD
    • DESCARTES
    • DIABESITY
    • ERN
    • EUDIAL
    • EURECA-m
    • IWG
    • WGIKD
  • Committees
    • SAB
    • YNP
    • ECC
    • GNC
    • NPPC
    • Ethics Committee
    • Registry
    • ERBP

News

Direct-acting antiviral agents improve kidney survival in hepatitis C virus-associated cryoglobulinemia

News, News-Home

Up to 50% of patients with hepatitis C virus (HCV) infection have elevated cryoglobulin levels, but only 2-3% develop vasculiticsymptoms of HCV-related mixed cryoglobulinemia (HCV-MC). The recently introduced direct antiviral agents (DAA) have yielded high rates of sustainable viral response in chronic HCV infection, even in chronic kidney disease patients. The RENALCRYOGLOBULINEMIC observational multicentre cohort […]

Read more
12 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/m_sfz178f1.png 370 520 ERA-EDTA ERA-EDTA2020-02-12 08:48:302020-02-12 08:48:30Direct-acting antiviral agents improve kidney survival in hepatitis C virus-associated cryoglobulinemia

New GlomCon/ERA-EDTA Webinar on “Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy”!

News, News-Home

The new GlomCon/ERA-EDTA roundtable discussion is scheduled tomorrow, February 14, 2020 at 5 pm CET, 4 pm GMT and 8 am PST. Dr Rianne Boenink will discuss on “Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy”. The moderator will be Dr Sokratis Stoumpos and the panelists will be Prof Kitty J. […]

Read more
10 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/EQSUPh4VUAAOEr4.jpeg 1080 2160 ERA-EDTA ERA-EDTA2020-02-10 09:24:022020-02-10 09:24:22New GlomCon/ERA-EDTA Webinar on "Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy"!

Did you miss the CTDay2019? View the webcast!

News, News-Home

The webcast of the CTDay (Clinical Transplantation Day), held on November 29,2019 in Barcelona (Spain), is available on the ERA-EDTA website. The access to the webcast is for healthcare professionals only. View the webcast https://www.era-edta.org/en/virtual-meeting/#!resourcegroups/event_ids=253&page=1

Read more
6 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/CTDay2019_banner500X250.png 250 508 ERA-EDTA ERA-EDTA2020-02-06 10:28:232020-02-06 10:37:22Did you miss the CTDay2019? View the webcast!

The newest recommendations from the Pediatric Renal Nutrition Taskforce

News, News-Home

Both malnutrition and obesity are important problems in children with chronic kidney disease (CKD). The latest recommendations from the Pediatric Renal Nutrition Taskforce wererecently published to help guide nutritional recommendations for children with CKD stages 2–5 and those on dialysis. They emphasize the importance of breastfeeding or feeding with breastmilk for infants with CKD. The […]

Read more
6 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/2020-02-06_10-19.png 516 614 ERA-EDTA ERA-EDTA2020-02-06 10:21:422020-02-06 10:21:42The newest recommendations from the Pediatric Renal Nutrition Taskforce

Soluble urokinase-type plasminogen activator receptor levels are independent of primary cause of idiopathic nephritic syndrome

News, News-Home

Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are increased in inflammation and have been associated with endothelial dysfunction and cardiovascular risk. Patients with nephrotic syndrome (NS) show signs of endothelial dysfunction and so suPAR levels were evaluated in 152 patients with idopathic NS due to minimal change disease, focal segmental glomerulosclerosis or membranous […]

Read more
5 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/sfz173f1.png 4600 4000 ERA-EDTA ERA-EDTA2020-02-05 08:09:162020-02-05 08:09:16Soluble urokinase-type plasminogen activator receptor levels are independent of primary cause of idiopathic nephritic syndrome

Results from the 2012-18 DOPPS in the Gulf Cooperation Council countries now available

News, News-Home

The newest results from the prospective cohort Dialysis Outcomes and Practice Patterns Study (DOPPS) in the Gulf Cooperation Council (GCC) describe Kt/V achievement, its predictors and its relationship with mortality. The analysis included 1544 patients aged ≥18 years dialyzed for at least 180 days in Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab […]

Read more
3 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/sfz195f1.png 1390 2620 ERA-EDTA ERA-EDTA2020-02-03 20:56:452020-02-03 20:56:45Results from the 2012-18 DOPPS in the Gulf Cooperation Council countries now available

What should a nephrologist know about surgical assessment of potential renal transplant recipients?

News, News-Home

Pre-emptive transplantation is the optimum renal replacement therapy in terms of increasing life expectancy, improving quality of life and achieving the highest cost-effectiveness. Planning for the procedure requires an understanding of the following technical preconditions for successful transplant surgery: arterial and venous factors, urinary drainage, organ and recipient factors. Vasculature should be carefully evaluated in […]

Read more
3 February 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/02/m_gfz253f1.jpg 238 520 ERA-EDTA ERA-EDTA2020-02-03 11:31:182020-02-03 11:31:18What should a nephrologist know about surgical assessment of potential renal transplant recipients?

Clinical considerations and strategies for treating hypertension in CKD patients

News, News-Home

Hypertension is both a major cause and consequence of chronic kidney disease (CKD). It is associated with increased risk of cardiac events, stroke and kidney disease progression. The latest National Kidney Foundation Clinical Practice Guidelines recommend a blood pressure goal of <130mmHg systolic and <80mmHg diastolic for all CKD patients, regardless of the level of […]

Read more
31 January 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2019/10/patient_img_home.jpg 700 1000 ERA-EDTA ERA-EDTA2020-01-31 11:36:442020-01-31 11:36:44Clinical considerations and strategies for treating hypertension in CKD patients

Vitamin K supplementation protects kidneys and heart

News, News-Home

Vitamin K naturally occurs as type 1, which predominantly activates hepatic, i.e. coagulation-relevant vitamin K-dependent proteins (VKDPs), and type 2, activating the extra-hepatic VKDPs, including the Matrix gla protein (MGP) and osteocalcin. The latter VKDPs seem to be involved in the prevention of ectopic mineralization, thus contributing to cardiovascular disease prevention. Patients with chronic kidney […]

Read more
30 January 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/01/m_gfz291f1_rid.png 321 513 ERA-EDTA ERA-EDTA2020-01-30 09:11:262020-01-30 09:11:26Vitamin K supplementation protects kidneys and heart

The EQUAL study reports an association between kidney function decline and symptom development

News, News-Home

Patients with advanced chronic kidney disease (CKD) suffer from a wide range of symptoms influencing their quality of life, morbidity and mortality rates. In order to provide better insight into the association between kidney function decline and symptom development in elderly patients with advanced CKD (eGFR ≤20mL/min/1.73m2) a prospective European Quality study on treatment in […]

Read more
29 January 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/01/m_gfz277f3.png 322 520 ERA-EDTA ERA-EDTA2020-01-29 10:10:212020-01-29 10:10:21The EQUAL study reports an association between kidney function decline and symptom development
Page 3 of 9‹12345›»
  • Share on Facebook
  • Share on Twitter
  • Share on Pinterest
  • Share on Linkedin
  • Share on Reddit
  • Share by Mail
  • Share on WhatsApp

ERA-EDTA Operative Headquarters
Via XXIV Maggio 38
43123 Parma – Italy
Phone: +39 0521 989078
Fax: +39 0521 959242
E-mail: secretariat@era-edta.org

ERA-EDTA Registered Office
c/o PKF Littlejohn, 15 Westferry Circus, Canary Wharf
London E14 4HD – United Kingdom

You are here: Home / News

  • ABOUT ERA-EDTA
  • CONGRESS & MEETINGS
  • JOURNAL & PRESS
  • EDUCATION
  • PUBLIC AFFAIRS
  • GUIDELINES

  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
.av-share-box ul li{ display: none!important; }

  • Share on Facebook
  • Share on Twitter
  • Share on Pinterest
  • Share on Linkedin
  • Share on Reddit
  • Share by Mail
  • Share on WhatsApp
© Copyright - Era-Edta
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKLearn more